[ TRANSACTION RECORD ]

Novo Nordisk Foundation Investment in Biotech Innovation Fund — 2026

VERIFIED VECTOR ID: 002730 · tx-445
M SOURCE NODE — FUNDER
Healthcare Denmark
$2,500,000,000
EQUITY
15/02/2026
Q DESTINATION NODE — RECIPIENT
Fund Denmark
Amount (USD)
$2.5B
Flow Type
EQUITY
Transaction Date
15/02/2026
Primary Source
Funder Profile [ M ]
AUM 130000
HQ Location Denmark
Sector Healthcare
Recipient Profile [ Q ]
Entity Type Fund
Jurisdiction Denmark
Intelligence Note

Novo Holdings A/S committed 2.5 billion dollars in equity to the Biotech Innovation Fund to lead growth funding rounds for startups in life sciences and pharmaceutical technology. This transaction aims to drive the commercialization of advanced therapies and the global bio-economy. The deal highlights the role of healthcare conglomerates in driving the development of future medical systems.